Sarah Pett

8.7k total citations
10 papers, 311 citations indexed

About

Sarah Pett is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Sarah Pett has authored 10 papers receiving a total of 311 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Infectious Diseases, 3 papers in Virology and 3 papers in Epidemiology. Recurrent topics in Sarah Pett's work include HIV Research and Treatment (3 papers), Influenza Virus Research Studies (3 papers) and Respiratory viral infections research (3 papers). Sarah Pett is often cited by papers focused on HIV Research and Treatment (3 papers), Influenza Virus Research Studies (3 papers) and Respiratory viral infections research (3 papers). Sarah Pett collaborates with scholars based in Australia, United Kingdom and United States. Sarah Pett's co-authors include Jens Lundgren, Andrew Phillips, Martyn A. French, Frederikke F. Rönsholt, Álvaro H. Borges, Michael J. Vjecha, Jemma L. O’Connor, James D. Neaton, Fred M. Gordin and Gerd Fätkenheuer and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and AIDS Research and Human Retroviruses.

In The Last Decade

Sarah Pett

9 papers receiving 306 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sarah Pett Australia 7 184 116 111 105 30 10 311
Ravinder Kaur Sachdeva India 9 142 0.8× 141 1.2× 79 0.7× 98 0.9× 24 0.8× 26 320
Camille E. Puronen United States 5 155 0.8× 169 1.5× 139 1.3× 110 1.0× 23 0.8× 8 348
Alba Bigoloni Italy 11 247 1.3× 203 1.8× 142 1.3× 59 0.6× 14 0.5× 31 355
Romualdo Mazzi Italy 8 142 0.8× 74 0.6× 103 0.9× 128 1.2× 20 0.7× 16 316
Catalina Robledano Spain 11 169 0.9× 77 0.7× 114 1.0× 147 1.4× 16 0.5× 15 321
V. Jubault France 7 102 0.6× 83 0.7× 74 0.7× 65 0.6× 16 0.5× 9 222
Francesca Sabbatini Italy 10 85 0.5× 65 0.6× 89 0.8× 55 0.5× 27 0.9× 19 249
P Santopadre Italy 9 116 0.6× 77 0.7× 72 0.6× 131 1.2× 15 0.5× 9 314
Alessandra Calabresi Italy 10 150 0.8× 94 0.8× 93 0.8× 78 0.7× 11 0.4× 15 297
Sven Philip Aries Germany 8 122 0.7× 105 0.9× 72 0.6× 86 0.8× 47 1.6× 12 347

Countries citing papers authored by Sarah Pett

Since Specialization
Citations

This map shows the geographic impact of Sarah Pett's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Pett with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Pett more than expected).

Fields of papers citing papers by Sarah Pett

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sarah Pett. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Pett. The network helps show where Sarah Pett may publish in the future.

Co-authorship network of co-authors of Sarah Pett

This figure shows the co-authorship network connecting the top 25 collaborators of Sarah Pett. A scholar is included among the top collaborators of Sarah Pett based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sarah Pett. Sarah Pett is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

10 of 10 papers shown
2.
Wu, Chieh‐Hsi, Marc Hardwick, J. Kenneth Baillie, et al.. (2022). Impact of Dexamethasone and Remdesivir on Neurological Complications during COVID-19. SSRN Electronic Journal. 1 indexed citations
3.
Davey, Richard T., Eduardo Fernández‐Cruz, Norman Markowitz, et al.. (2019). Influenza Immunoglobulin for Adults Hospitalized with Influenza. SSRN Electronic Journal. 1 indexed citations
4.
Vanderven, Hillary A., Kathleen M. Wragg, Fernanda Ana‐Sosa‐Batiz, et al.. (2018). Anti-Influenza Hyperimmune Immunoglobulin Enhances Fc-Functional Antibody Immunity During Human Influenza Infection. The Journal of Infectious Diseases. 218(9). 1383–1393. 9 indexed citations
5.
Borges, Álvaro H., Jemma L. O’Connor, Andrew Phillips, et al.. (2015). Factors Associated With Plasma IL-6 Levels During HIV Infection. The Journal of Infectious Diseases. 212(4). 585–595. 127 indexed citations
6.
Borges, Álvaro H., Jemma L. O’Connor, Andrew Phillips, et al.. (2014). Determinants of IL‐6 levels during HIV infection. Journal of the International AIDS Society. 17(4S3). 19482–19482. 8 indexed citations
7.
Davey, Richard T., Ruth Lynfield, Dominic E. Dwyer, et al.. (2013). The Association between Serum Biomarkers and Disease Outcome in Influenza A(H1N1)pdm09 Virus Infection: Results of Two International Observational Cohort Studies. PLoS ONE. 8(2). e57121–e57121. 49 indexed citations
8.
Babiker, Abdel G., Sean Emery, Gerd Fätkenheuer, et al.. (2012). Considerations in the rationale, design and methods of the Strategic Timing of AntiRetroviral Treatment (START) study. Clinical Trials. 10(1_suppl). S5–S36. 94 indexed citations
9.
Suzuki, Kazuo, Gilbert R. Kaufmann, Motokazu Mukaide, et al.. (2001). Novel Deletion of HIV Type 1 Reverse Transcriptase Residue 69 Conferring Selective High-Level Resistance to Nevirapine. AIDS Research and Human Retroviruses. 17(13). 1293–1296. 9 indexed citations
10.
Pett, Sarah, Jane Tizard, Giorgina Mieli‐Vergani, et al.. (1987). Pediatric liver transplantation: Cambridge/King's series, December 1983 to August 1986.. PubMed. 19(4). 3256–60. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026